LK

Lorence Kim

Managing Partner at Ascenta Capital

New York, New York

Overview 

Lorence Kim is the Co-founder and Managing Partner at Ascenta Capital in New York, where he has successfully invested in companies like Odyssey Therapeutics and ADARx Pharmaceuticals. With a background that includes serving as the Chief Financial Officer at Moderna and a Managing Director at Goldman Sachs, Lorence has a strong track record in the biotech and pharmaceutical sectors, making impactful contributions as an Independent Board Member at REVOLUTION Medicines and other organizations.

Work Experience 

  • Co-founder and Managing Partner

    2023 - Current

Ascenta Capital is a private equity and venture capital firm.

  • Independent Board Member

    2022

Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

Raised $2,004,400,000.00 from Nextech Invest, Boxer Capital, Schroder Adveq, Cormorant Capital, Casdin Capital, Vivo Capital, Biotechnology Value Fund, Deerfield Capital Management, Third Rock Ventures and Fidelity.

  • Independent Board Member

    2022

Cencora is a global healthcare company that advances the development and delivery of pharmaceuticals and healthcare products.

Raised $3,025,000,000.00.

  • Board Member

    2021

Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.

Raised $95,000,000.00 from Bristol-Myers Squibb.

  • Board Member

    2021

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Raised $205,000,000.00 from GordonMD Global Investments, Boxer Capital, Third Rock Ventures, Nextech Invest, Invus, Eventide, Pavilion Capital Partners, Agent Capital, Casdin Capital and Shangbay Capital.

  • Independent Board Member

    2022 - 2023

Sustainable Private Equity and Credit Investments

  • Venture Partner

    2020 - 2022

  • Board Member

    2014 - 2020

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Raised $537,800,000.00 from Oaktree Capital Management.

  • Chief Financial Officer

    2014 - 2020

  • Managing Director

    2000 - 2014

    Co-head of Biotechnology Investment Banking

Goldman Sachs is a multinational financial services firm providing securities, investment banking, and management services.

Articles About Lorence

Relevant Websites